ACA
TLSI icon

Apis Capital Advisors’s TriSalus Life Sciences TLSI Stock Holding History

Apis Capital Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$720K Buy
+180,000
New +$881K 0.11% 46

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Apis Capital Advisors's TLSI Position: Q1 2026 in Review

Apis Capital Advisors opened a new position in TriSalus Life Sciences (TLSI) in Q1 2026: 180,000 shares worth $720K. The stake represents 0.11% of the portfolio and ranks #46 among its holdings.

84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Apis Capital Advisors held 180,000 shares of TriSalus Life Sciences worth $720K as of Q1 2026.
  • TriSalus Life Sciences was a new Apis Capital Advisors position in Q1 2026.
  • TriSalus Life Sciences made up 0.11% of Apis Capital Advisors's portfolio in Q1 2026, its #46 holding.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Apis Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.